<DOC>
	<DOCNO>NCT00088296</DOCNO>
	<brief_summary>This study examine effect morphine leuteinizing hormone , testosterone , adrenocorticotropic hormone cortisol men . The use long-term opioids , morphine , treat patient pain increase , despite dearth information effect hormone . The study also look effect chronic pain hormone level effect placebo pain . Men 30 65 year age moderate severe chronic pain due osteoarthritis least 3 month healthy , pain-free men age range may eligible study . Patients take opioid-based medication percocet , vicodin , morphine pain relief , well patient take opioids , may participate . Candidates screen medical history , physical examination , blood test , include blood test look possible `` pain gene , '' electrocardiogram , x-ray , questionnaires assess impact pain functional level psychological well . This four-part study . Healthy volunteer patient take opioids arthritis pain end participation Part I ; take opioids continue Parts II , III , IV , follow : Part I : Participants admit NIH Clinical Center 4 p.m. overnight stay . At 6 p.m. catheter ( plastic tube ) place vein forearm remain place throughout night . Blood sample 3 cc 's ( less teaspoon ) collect catheter every 20 minute 12 hour , 8 p.m. 8 a.m . Participants also collect urine start 8 a.m. morning hospital admission continue collection throughout 24-hour hospital stay . Patients discharge completion blood sampling . Part II : Patients randomly assign take morphine ( MS Contin ) , placebo , standard treatment , consist anti-inflammatory medication acetaminophen need , opioids . ( Patients group I II also permit take anti-inflammatory drug acetominophen , addition study medication . ) Patients monitored drug side effect phone twice week , medication dos adjust need . The morphine dose gradually increased 4-week period side effect develop . After 2 week high dose morphine , hormone blood level measure patient complete questionnaire . Patients readmitted hospital repeat blood sample blood collection Part I . Patients morphine placebo gradually taper drug 12 day remain drug-free 2 day start Part III . Part III : All patient give morphine part study monitor drug side effect phone twice week , dos adjust need . The morphine gradually increase 6-week period side effect develop maintain high dose another 8 week . Hormone level measure blood urine study questionnaire repeat . Patients interested continue long-term treatment MC Contin refer back physicians recommendation effect . Part IV : Patients follow phone 6 month , time return Clinical Center hormone level measurement , repeat blood urine test , questionnaire .</brief_summary>
	<brief_title>Effects Osteoarthritis Pain , Morphine , Placebo Neuroendocrine Function Men</brief_title>
	<detailed_description>Several study suggest acceptance use opioid medicine relief chronic pain increase substantially , opiodergic medication chronic pain perturb neuroendocrine function , especially hypothalamic pituitary , adrenal , gonadal ax . The objective propose protocol , entitle `` Effects Chronic Musculoskeletal Pain Opioidergic versus Placebo Interventions Neuro-endocrine Function Men , '' three fold : 1 . To determine whether long term opioid usage men chronic pain due osteoarthritis result abnormality ACTH , cortisol , LH testosterone secretion . 2 . To evaluate whether placebo analgesia result similar hormonal response elicit opioid analgesic . Prior image study show placebo analgesia associate activation similar part cortex analgesic intake . 3 . To evaluate effect chronic pain per se ACTH , cortisol , LH testosterone secretion . To address question , propose 4-part study . In part I , 12 healthy men compare 12 men chronic osteoarthritis ( OA ) pain long term opioids 12 narcotic naive men chronic OA pain mean 12 hour overnight frequent blood sample measurement cortisol , ACTH , LH testosterone . In part II , 36 narcotic naive patient chronic OA , pain , undergone overnight hormone sample Part I , randomize one three treatment group : MS Contin ( 15-90 mg ) , placebo `` standard treatment . '' Doses placebo MS Contin escalate 4 week similar fashion two-week maintenance 2 week taper . At end maintenance 6 week , patient return repeat 12 hour frequent sample hormone Part I . At end part II , patient invite go open label treatment period MS Contin ( 15-120 mg ) part III study , consist 6-week dose escalation 8 week maintenance . At point patient refer back physician recommendation continue treatment MS Contin , patient interested option . Patients follow phone 6 month . At point ask return clinic part IV , outpatient AM sample testosterone , LH , ACTH cortisol . The primary endpoint study measure LH , testosterone , ACTH , cortisol secretion , whereas secondary endpoint neurobehavioral index pain bothersomeness visual analog scale , Oswestry Disability Index , Multidimensional Pain Inventory , Beck Depression Inventory . It anticipate study provide novel information regard effect chronic musculoskeletal pain , treatment opioids versus placebo , select neuroendocrine function men .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Clinical evidence chronic OA history examination major joint spine . 1 . Pain level 4/10 great scale 0 10 2 . Pain duration 3 month longer present least 5 7 day week 3 . Radiographic evidence moderate severe OA involve joint base Kellgren Lawrence score scale . 2 . Age 3065 study entry 3 . Men ethnicities 4 . Ability understand study measure mentally capable give consent participate study ( base 8th grade education level ) 5 . Willingness refrain take opioids dictate study design EXCLUSION CRITERIA : 1 . Impaired pulmonary , renal , hepatic , cardiovascular endocrinemetabolic function ; major coexist medical condition cancer , chronic obstructive pulmonary disease severe hepatic renal dysfunction 2 . Primary secondary endocrine disease diabetes Cushing 's syndrome 3 . Prostatic disease require usage urological medication 4 . Presence sexual dysfunction define lack libido , impotence erectile abnormality . 5 . Current symptom coronary artery disease 6 . Presence RA , type inflammatory arthritis 7 . Use systemic corticosteroid two month screen study entry 8 . Alcohol abuse year prior study enrollment 9 . Usage recreational drug 10 . History narcotic abuse time past 11 . Major depression whether successfully unsuccessfully treat diagnosed time study screen base score great equal 20 Beck Depression Inventory 12 . Hct le 35 ; anemia bleed disorder 13 . Allergy morphine 14 . Current past history fibromyalgia describe Wolfe F et al. , ( 1990 ) ( minimum 12 19 point tenderness must present satisfy criterion fibromyalgia ) 15 . Cognitive impairment individual unable give inform consent , complete study data collection tool require study visit 16 . Age 29 year less due rarity OA age group 17 . Body mass index ( BMI ) great 30kg/m ( 2 ) BMI le 20kg/m ( 2 ) Usage nonsteroidal antiinflammatory drug ( NSAIDs ) allow study entry conduct study . Patients ask refrain use muscle relaxer , opioids apart study drug ( MS Contin ) , AED 's ( antiepileptic drug ) , TCAs ( tricyclic antidepressant ) , SSRIs ( selective serotonin reuptake inhibitor ) benzodiazepine pain control part II III . Patients also ask refrain local joint injection steroids agent . Patients query regard use complementary and/or alternative medicine ( CAM ) treatment ( e.g . acupuncture , chiropractic manipulation , herb botanical , mindbody intervention ) start study counsel begin CAM treatment study protocol . Starting treatment study consider study violation . The exception glucosamine and/or chondroitin .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 18, 2007</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>MS Contin</keyword>
	<keyword>Placebo</keyword>
	<keyword>Cortisol</keyword>
	<keyword>Testosterone</keyword>
	<keyword>Degenerative Joint Disease</keyword>
	<keyword>OA</keyword>
	<keyword>Arthritis</keyword>
	<keyword>Joint Pain</keyword>
	<keyword>Arthritic Pain</keyword>
	<keyword>Opioid</keyword>
</DOC>